Sulfation is an important pathway of thyroid hormone metabolism that facili
tates the degradation of the hormone by the type I iodothyronine deiodinase
, but little is known about which human sulfotransferase isoenzymes are inv
olved. We have investigated the sulfation of the prohormone T-4, the active
hormone T-3, and the metabolites rT(3) and 3,3'-diiodothyronine (3,3'-T-2)
by human liver and kidney cytosol as well as by recombinant human SULT1A1
and SULT1A3, previously known as phenol-preferring and monoamine-preferring
phenol sulfotransferase, respectively. In all cases, the substrate prefere
nce was 3,3'-T-2 much greater than rT(3) > T-3 > T-4. The apparent K-m Valu
es of 3,3'-T-2 and T-3 [at 50 mu mol/L 3'-phosphoadenosine-5'-phosphosulfat
e (PAPS)] were 1.02 and 54.9 mu mol/L for liver cytosol, 0.64 and 27.8 mu m
ol/L for kidney cytosol, 0.14 and 29.1 mu mol/L far SULT1A1, and 33 and 112
mu mol/L for SULT1A3, respectively. The apparent K-m of PAPS (at 0.1 mu mo
l/L 3,3'-T-2) was 6.0 mu mol/L for liver cytosol, 9.0 mu mol/L for kidney c
ytosol, 0.65 mu mol/L for SULT1A1, and 2.7 mu mol/L for SULT1A3. The sulfat
ion of 3,3'-T-2 was inhibited by the other iodothyronines in a concentratio
n-dependent manner. The inhibition profiles of the 3,3'-T-2 sulfotransferas
e activities of liver and kidney cytosol obtained by addition of 10 mu mol/
L of the various analogs were better correlated with the inhibition profile
of SULT1A1 than with that of SULT1A3. These results indicate similar subst
rate specificities for iodothyronine sulfation by native human liver and ki
dney sulfotransferases and recombinant SULT1A1 and SULT1A3. Of the latter,
SULT1A1 clearly shows the highest affinity for both iodothyronines and PAPS
, but it remains to be established whether it is the prominent isoenzyme fo
r sulfation of thyroid hormone in human liver and kidney. (J Clin Endocrino
l Metab 84: 1357-1364, 1999).